Raise by Fusion42
Fusion42 Scout Wire
Capital Reports
Who's InvestingWeekly · Mon 08:00 UTCCapital UnlockedBi-weekly · Wed 08:00 UTC
Benchmarks
Benchmarks HomeFundsRoundsSectors
AI VC IndexCapital FlowAbout

Switch product

Fusion42RaiseScoutWire

Capital Reports

All editionsWho's InvestingWeekly · Mon 08:00 UTCCapital UnlockedBi-weekly · Wed 08:00 UTC

Database & benchmarks

Benchmarks HomeFundsRoundsSectorsStagesAI VC IndexCapital Flow Index

Account

Sign in
← Back

Luma Group | LumaBio Fund I

vc$410MCo-investsLeads rounds

◆ Fund Size

$410M

◆ Location

United States

◆ Portfolio

10 companies

◆ Activity

Statusactively investing

◆ Links

Website ↗

◆ Share this fund

ShareXLinkedInEmail

◆ Investment Thesis

Luma Group is a multistage investment firm focused on biotechnology, bringing together scientific insight and computation to shape both its investment strategy and the companies it backs. The firm partners with teams that have deep biological conviction—grounded in data and clear paths to translation—that can become durable, scalable patient impact. It backs teams translating breakthrough science into therapies, diagnostics, and medical devices that can scale impact for patients.

◆ About Luma Group

A 15-year life sciences venture capital fund focused on investing early in exceptional entrepreneurs advancing transformative science at the convergence of biology, chemistry, physics and artificial intelligence, with flexibility to support companies from discovery to commercialization.

◆ Sectors

BiotechDrug Discovery

◆ Stages

pre-seedseedseries-aseries-b

◆ Geography Focus

GlobalUnited StatesEuropeIsrael

◆ Team

NameTitleRoleLinks
Bill RyanChief Financial OfficerSenior
James "JJ" Stankowicz, PhDHead of AI & EngineeringSenior
Jamie Kasuboski, PhDPartner & Head of ResearchSenior
Josh FinkFounder & Managing MemberSenior
Negin Mokhtari, PhDVenture Partner & Chief Strategy Officer of LABISenior
Richard Ebright, MD, PhDScience FellowSenior
Rosana Kapeller, MD, PhDVenture PartnerSenior
Themasap Khan, PhDCo-Founder & PartnerSenior
James Kasuboski, PhDPartner—
John GomezSenior AssociateMid
Joshua FinkFounder and Managing Member—
Matt OckoPartner—
Nora McCarthyAdministrative AssistantJunior
Richie SantryChief of StaffMid
Rishabh Mishra, MDClinical AdvisorMid
Tamara YoungExecutive AssistantJunior

◆ Notable Investments

Aeovian PharmaceuticalsAltos LabsArsenal BiosciencesCharacter BiosciencesCoultreon BiopharmaCurve BiosciencesIntegrated BiosciencesRome TherapeuticsSciTheraVaccine Company (Acquired by Eli Lilly, 2026)Vaccine CompanyROME Therapeutics

◆ Traits

Leads rounds

Co-invests

◆ FAQ

What does LumaBio Fund I invest in?

LumaBio Fund I invests in Biotech and Drug Discovery at the pre-seed, seed, series-a and series-b stages.

Which geographies does LumaBio Fund I focus on?

LumaBio Fund I focuses on Global, United States, Europe and Israel, and is headquartered in United States.